Effect of Omega-3 Fatty Acid on Cortical Function in ADHD

• Status: Completed
• Trial end date: 2017-03-03
• Target enrollment: 0
• Participant gender: All

Summary

The study hypothesis is that DHA is more effective than placebo in increasing brain activation and reducing symptoms in psychostimulant-free children with ADHD.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cincinnati
• Collaborator: DSM Nutritional Products, Inc.

Criteria

Inclusion Criteria:

• Provision of written informed consent/assent

• Ages 5-15 years old

• Meets DSM-IV-TR criteria for ADHD as determined by the KSADS

Exclusion Criteria:

• Contraindication to an MRI scan (i.e., braces, claustrophobia)

• A history of a major medical (e.g., diabetes) or neurological illness (e.g., epilepsy)

• Greater than 1 year outside appropriate age/grade level

• A history of intolerance or hypersensitivity to omega-3 fatty acids

• Currently taking omega-3 supplements

• Not proficient in English language

• Any history of a hematological disorder or concomitant use of anticoagulant medications

• Personal history of an Axis I psychiatric disorder other than ADHD

• Inability to swallow capsules